EGFR and non-small cell lung carcinoma: Zhou et al.15 analyzed EGFR mutations of 261 patients with pathologically confirmed NSCLC from West China Hospital, and observed that the EGFR mutation rate was 48.7%, with smoking status and pathological types as independent predictors.